BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, Katayama N, Uemoto S, Ishizashi H, Matsumoto M, Fujimura Y, Isaji S. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009;124:541-545. [PMID: 19423151 DOI: 10.1016/j.thromres.2009.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ekser B, Lin CC, Long C, Echeverri GJ, Hara H, Ezzelarab M, Bogdanov VY, Stolz DB, Enjyoji K, Robson SC, Ayares D, Dorling A, Cooper DK, Gridelli B. Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation. Transpl Int. 2012;25:882-896. [PMID: 22642260 DOI: 10.1111/j.1432-2277.2012.01506.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Yokose T, Obara H, Shinoda M, Nakano Y, Kitago M, Yagi H, Abe Y, Yamada Y, Matsubara K, Oshima G, Hori S, Ibuki S, Higashi H, Masuda Y, Hayashi M, Mori T, Kawaida M, Fujimura T, Hoshino K, Kameyama K, Kuroda T, Kitagawa Y. Colon perforation due to antigenemia-negative cytomegalovirus gastroenteritis after liver transplantation: A case report and review of literature. World J Gastroenterol 2019; 25(15): 1899-1906 [PMID: 31057303 DOI: 10.3748/wjg.v25.i15.1899] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Arni D, Gumy-Pause F, Ansari M, Kremer Hovinga JA, McLin VA. Successful liver transplantation in a child with acute-on-chronic liver failure and acquired thrombotic thrombocytopenic purpura. Liver Transpl 2015;21:704-6. [PMID: 25727917 DOI: 10.1002/lt.24096] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Matsuda D, Toshima T, Ikegami T, Harimoto N, Yamashita Y, Yoshizumi T, Soejima Y, Ikeda T, Shirabe K, Maehara Y. Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case. Clin J Gastroenterol 2014;7:159-63. [DOI: 10.1007/s12328-013-0446-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Takahashi N, Usui M, Naitoh K, Wada H, Mastsui T, Kobayashi T, Matsumoto T, Uemoto S, Isaji S. Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation. Clin Appl Thromb Hemost 2017;23:274-81. [PMID: 26346441 DOI: 10.1177/1076029615604047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Int J Hepatol 2011;2011:759047. [PMID: 21994870 DOI: 10.4061/2011/759047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
7 Ko S, Chisuwa H, Matsumoto M, Fujimura Y, Okano E, Nakajima Y. Relevance of ADAMTS13 to liver transplantation and surgery. World J Hepatol 2015; 7(13): 1772-1781 [PMID: 26167250 DOI: 10.4254/wjh.v7.i13.1772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
8 Habe K, Wada H, Ito-habe N, Hatada T, Matsumoto T, Ohishi K, Maruyama K, Imai H, Mizutani H, Nobori T. Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related Diseases. Thrombosis Research 2012;129:598-602. [DOI: 10.1016/j.thromres.2011.10.011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
9 Verbiest A, Pirenne J, Dierickx D. De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Reviews 2014;28:269-79. [DOI: 10.1016/j.blre.2014.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
10 Shindoh J, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Yamashiki N, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N. Thrombotic Microangiopathy After Living-Donor Liver Transplantation: TMA After LDLT. American Journal of Transplantation 2012;12:728-36. [DOI: 10.1111/j.1600-6143.2011.03841.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
11 Mizuno S, Wada H, Hamada T, Nobuoka Y, Tabata M, Nobori T, Isaji S. Lethal hepatic infarction following plasma exchange in living donor liver transplant patients. Transpl Int 2011;24:e57-8. [PMID: 21382102 DOI: 10.1111/j.1432-2277.2011.01244.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Nobuoka Y, Wada H, Mizuno S, Kishiwada M, Usui M, Sakurai H, Tabata M, Kobayashi T, Nobori T, Uemoto S, Isaji S. Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol 2014;99:418-28. [PMID: 24595551 DOI: 10.1007/s12185-014-1543-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Takahashi N, Wada H, Usui M, Kobayashi T, Habe-Ito N, Matsumoto T, Uemoto S, Nobori T, Isaji S. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation. Thromb Res 2013;131:225-9. [PMID: 23266519 DOI: 10.1016/j.thromres.2012.12.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
14 Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012;36:1102-1111. [PMID: 22374540 DOI: 10.1007/s00268-012-1496-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
15 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91:20-29. [PMID: 20054668 DOI: 10.1007/s12185-009-0481-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
16 Nakanuma S, Miyashita T, Hayashi H, Ohbatake Y, Takamura H, Okazaki M, Yamaguchi T, Sakai S, Makino I, Oyama K, Tajima H, Ninomiya I, Fushida S, Ohta T. Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report. Transplant Proc 2017;49:1596-603. [PMID: 28651806 DOI: 10.1016/j.transproceed.2017.02.047] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Rangarajan S, Kessler C, Aledort L. The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists. Thromb Res 2013;132:403-7. [PMID: 24050828 DOI: 10.1016/j.thromres.2013.07.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Czubkowski P, Pawłowska J, Jankowska I, Teisseyre M, Kamińska D, Markiewicz M, Ryżko J. Successful sirolimus rescue in tacrolimus-induced thrombotic microangiopathy after living-related liver transplantation. Pediatr Transplant 2012;16:E261-4. [PMID: 22066835 DOI: 10.1111/j.1399-3046.2011.01601.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]